Company Filing History:
Years Active: 1996-1997
Title: Berta Moritz: Innovator in Diagnostic Assays
Introduction
Berta Moritz is a distinguished inventor based in Vienna, Austria. She has made significant contributions to the field of diagnostic assays, particularly in the area of activated protein C sensitivity. With a total of 3 patents to her name, Moritz has demonstrated her expertise and commitment to advancing medical diagnostics.
Latest Patents
One of her latest patents is an assay for determining sensitivity to activated protein C. This innovative assay ensures rapid and accurate evaluations by measuring the conversion of added factor X to an activated form by activated factor VIII within a test sample. The sensitivity of the test sample is determined by the relative inhibition of factor X conversion compared to a control. A test sample with decreased sensitivity to activated protein C will exhibit relatively low inhibition, and vice versa.
Another notable patent is a method of assaying plasma proteins with prothrombin fragments. This patent discloses the use of prothrombin fragments, particularly human prothrombin fragments with thrombin-like activity, for diagnostic purposes. These fragments, including meizothrombin and desF1, are utilized for assaying thrombin substrates, showcasing Moritz's innovative approach to diagnostics.
Career Highlights
Berta Moritz is currently associated with Immuno Aktiengesellschaft, where she continues to contribute to the field of medical diagnostics. Her work has been pivotal in developing assays that enhance the accuracy and efficiency of diagnostic testing.
Collaborations
Throughout her career, Moritz has collaborated with notable professionals in her field, including Hartmut Lang and Manfred Oberreither. These collaborations have further enriched her research and development efforts.
Conclusion
Berta Moritz stands out as a prominent inventor in the realm of diagnostic assays. Her innovative patents and contributions to medical diagnostics reflect her dedication to improving healthcare outcomes.